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Cholesterol Homeostasis: Not Until
the SCAP Lady INSIGs
Christopher J.R. Loewen and Timothy P. Levine
Three new studies have wide implications for
cholesterol homeostasis, identifying a novel mecha-
nism by which a sterol-sensing domain functions in
the regulated activation of sterol regulatory element
binding proteins.
The regulation of cholesterol metabolism not only has
major implications for human health, but also has been
an important avenue for discovery of basic cellular
processes involved in membrane function. Lipid
metabolism pathways are typically regulated by co-
ordinated transcriptional control. For cholesterol, sterol
regulatory elements (SREs) are the target of a family of
three transcription factors called SRE-binding proteins
(SREBPs) [1], homologs of which are found in flies,
worms and some fungi. But SREBP does not bind lipid
directly, indicating the existence of a lipid-detecting
machinery. Just such machinery has been identified for
the first time in a series of new studies.
The transcriptionally active domain of SREBP is syn-
thesized in an inactive form as part of an integral mem-
brane protein of the endoplasmic reticulum (ER; Figure
1A). Activation of SREBP requires cleavage by two
proteases in the Golgi complex [2], which only gain
access to their substrate when SREBP is transported
from the ER to the Golgi — and this only occurs in the
absence of cholesterol. Some years ago, SREBP
cleavage-activating protein (SCAP) was identified as a
binding partner of SREBP [3]. Not only is SCAP
required for SREBP transport to the Golgi, but it also
imparts sterol regulation: the SCAP–SREBP complex
cannot exit the ER when cholesterol levels are high [4].
Since the discovery of SCAP, the main goal has
been to determine how cholesterol regulates its exit
from the ER. A detailed molecular dissection has led
to the prediction of an ER anchor for SCAP, which is
an integral membrane protein with two major domains
(Figure 1B). While SCAP’s cytoplasmic carboxyl ter-
minus interacts directly with the carboxy-terminal
domain of SREBP [5], its amino terminus consists of
eight transmembrane domains including a conserved
sterol-sensing domain. In humans, four other families
of proteins are known to contain sterol-sensing
domains, all performing functions related to choles-
terol metabolism (Figure 1B). 
Despite the circumstantial evidence that sterol-
sensing domains interact with sterols, no direct
evidence for such an interaction has yet been obtained
[6]. Nevertheless, for SCAP, two lines of evidence
implicate the sterol-sensing domain as the site of
regulation. Firstly, mutations in the sterol-sensing
domain cause a gain of SREBP function, with constitu-
tive transport to the Golgi that is resistant to high levels
of sterols [7]. Secondly, the same constitutive transport
is seen with overproduction of just the sterol-sensing
domain of SCAP, indicating that an ER-localized
anchor is saturated by high levels of this domain [8].
Brown, Goldstein and co-workers [9] have now
identified an ER anchor protein for the sterol-sensing
domain of SCAP as the polytopic protein INSIG-1 (also
called CL-6). Little is known about this protein, except
that transcription of its mRNA in hepatic cells is
rapidly induced by insulin — hence its name INSulin-
Induced Gene-1 [10]. What is exciting about the
interaction between INSIG-1 and SCAP is that it is
enhanced by sterols, exactly as would be predicted
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Figure 1. Domain structure and membrane topology of SREBP
and proteins involved in its regulation.
(A) SREBP has two transmembrane domains and two cyto-
plasmic domains, one of which is a transcription factor domain
(diamond) that is released from the membrane by the sequen-
tial action of two Golgi proteases (indicated by the scissors). 
(B) Sterol-sensing domains have five transmembrane domains
(boxed) and have been found in five protein families connected
to cholesterol metabolism: SCAP, which binds SREBP via its
cytoplasmic domain (oval); HMG-CoA reductase (HMGR) with
a cytoplasmic catalytic domain (star), and 7-dehydrocholesterol
reductase (DHCR), both enzymes on the sterol biosynthetic
pathway; Niemann-Pick type C protein 1 (NPC1), involved in
trafficking of intracellular lipids; and patched (PTC) which binds
cholesterol-modified signaling proteins. Except for PTC, related
proteins are also found in fungi, for example HMG CoA reduc-
tase in S. pombe (right-hand column). (C) INSIG-1 and its close
homolog INSIG-2 are binding partners for the sterol-sensing
domain of SCAP. Both these proteins share the following fea-
tures with the predicted protein NP_587813 in S. pombe (right-
hand column): size (280 residues), topology (five putative
transmembrane domains) and a conserved hydrophilic loop
(FDRSRxG). A similar gene product is also predicted in N.
crassa (not shown). In all cases, the diagrams show proteins
with their cytoplasmic surface upwards.
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for a cholesterol-mediated anchor (Figure 2). As
expected, binding of INSIG-1 is weaker to forms of
SCAP that undergo constitutive transport because of
sterol-sensing domain mutations. In addition, high
levels of SCAP require overproduction of INSIG-1 to
re-establish sterol regulation of SREBPs, indicating
that a balance between these proteins is critical for
normal sterol homeostasis.
At what stage might INSIG-1 act in SCAP–SREBP
transport? Using an in vitro budding assay developed
earlier [4], Espenshade et al. [11] have now shown that
SCAP interacts with the ER budding machinery only in
the absence of sterols. Taken together with the uniform
distribution of INSIG-1 throughout the ER [9], it is there-
fore likely that binding of INSIG-1 to SCAP in the pres-
ence of cholesterol leads to ER retention by preventing
access to budding sites in transitional ER (Figure 2).
The biology of INSIGs now becomes a critical topic.
In a second new paper, Brown and Goldstein [12]
follow up this work to show that INSIG-2, the only other
human homologue to INS1G-1 (Figure 1C), also binds
SCAP, although with lower affinity. Interestingly, they
demonstrate a second difference between the INSIG
genes: INSIG-2 is expressed constitutively, while INSIG-
1 is itself a target of SREBP gene control, and is
repressed when SREBPs are inactivated. These find-
ings are confirmed in another recent paper [13] on
INSIG-1, which demonstrates rapid down-regulation of
INSIG-1 mRNA in the presence of sterols that act
through SREBP. This suggests a scheme whereby the
two INSIG proteins control SREBP over a wide range of
sterol concentrations. When sterols are in excess there
is little INSIG-1 expression, and SREBP is regulated by
INSIG-2 alone. However, when sterols are limiting,
INSIG-1 is induced, and its product regulates SREBP
with a greater sensitivity to low sterol levels [12].
A third new paper from the Goldstein and Brown
group [14] suggests how cholesterol regulates the
INSIG-1–SCAP–SREBP complex. Addition of choles-
terol to SCAP, either in whole cells or in microsomal
fractions, causes a slight change in the access of
trypsin to residues in the cytoplasmic loop that follows
the sterol-sensing domain (Figure 2A). The same
change occurs when SCAP is overproduced in insect
cells, implying that the effect is not mediated by
another protein. Furthermore, only a minority of variant
forms of cholesterol mediates the change in trypsin
digestion, and some enantiomers of cholesterol —
as well as oxidised cholesterol derivatives such as 
25-hydroxycholesterol, which potently inhibits SREBP
cleavage — do not. This indicates that, like other poly-
topic proteins [15], SCAP has a region, close to or
including the sterol-sensing domain, which undergoes
a conformational change in response to cholesterol
that increases its affinity for INSIG-1. This has strong
implications for the function of sterol-sensing domains
in general, although further experiments are required to
confirm the proposed interaction between cholesterol
and the sterol-sensing domain of SCAP and to deter-
mine the extent of the conformational change.
The requirement for tight control of cholesterol is
driven by the need that all cells have to regulate the
physical properties of their membranes. In sterol-
synthesizing eukaryotes, sterols are the single major
lipid component and increasing sterol concentration
raises membrane thickness and rigidity at the expense
of fluidity [16]. In the absence of sterols, other lipids
are adjusted to maintain membrane fluidity, both in
prokaryotes [17] and in sterol-auxotrophic eukaryotes
such as flies and nematode worms. 
In an elegant set of experiments, also from the
Brown and Goldstein group, the SCAP–SREBP
complex in fly cells was shown to respond to its major
phospholipid, phosphatidylethanolamine (PE) [18]. PE
differs from other common phospholipids by its
tendency to promote the formation of the inverted
hexagonal phase, rather than the lamellar phase, a
property also associated with sterols [19]. It is there-
fore intriguing that, although INSIG homologs are
clearly present throughout vertebrate evolution (the
Fugu genome has two), none has been found in either
Drosophila or Caenorhabditis genomes. This suggests
that flies may have a different SCAP-binding ER
protein that enables SCAP to detect PE. 
As model organisms such as Schizosaccharomyces
pombe and Neurospora crassa synthesize sterols and
have a variety of sterol-sensing domain proteins,
including HMG-CoA reductase (Figure 1B), it is
reassuring to note that they have distant INSIG
homologs (Figure 1C). Precisely how sterol sensors and
their binding partners function at the molecular level is
set to be the next fundamental aspect of biology to be
resolved in the name of cholesterol homeostasis.
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Figure 2. INSIG-1 regulates ER-to-Golgi
transport of SREBP.
(A) In the presence of cholesterol, INSIG-
1 interacts with SCAP; this is associated
with a conformational change detected 
by altered trypsin digestion of its third
cytoplasmic loop (*). The INSIG-1–SCAP–
SREBP complex is retained in the ER.
(B) In the absence of cholesterol, INSIG-1
has reduced affinity for SCAP, which
escorts SREBP laterally into transitional
ER, prior to budding in COPII-coated vesi-
cles.
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